Histopathological Analysis of Acinetobacter baumannii Lung Infection in a Mouse Model

Shigeru Tansho-Nagakawa1, Yoshinori Sato1, Tsuneyuki Ubagai1

  • 1Department of Microbiology and Immunology, Teikyo University School of Medicine, Tokyo, Japan.

Insights

Acinetobacter baumannii causes severe lung infections, persisting in mice for 14 days despite immune cell infiltration. This prolonged inflammation highlights the need for new treatments against this resilient pathogen.

Area of Science:

  • Microbiology
  • Immunology
  • Pathology

Background:

  • Acinetobacter baumannii is a primary cause of hospital-acquired infections, particularly severe lung infections.
  • Understanding the virulence and host-pathogen interactions of A. baumannii is crucial for developing effective treatments.

Purpose of the Study:

  • To compare the virulence of A. baumannii strains (ATCC 19606 and TK1090) with Pseudomonas aeruginosa PAO-1 in a murine lung infection model.
  • To analyze the histopathological changes and immune cell responses in the lungs following infection.

Main Methods:

  • C3H/HeN mice were intratracheally inoculated with A. baumannii or P. aeruginosa.
  • Survival rates were monitored for 14 days.
  • Lung tissues were collected at various time points for histopathological analysis, focusing on immune cell infiltration (neutrophils and macrophages).

Main Results:

  • A. baumannii strains exhibited lower lethality than P. aeruginosa but established a persistent lung bacterial burden up to 14 days post-infection.
  • Both A. baumannii and P. aeruginosa induced macrophage infiltration in lung foci.
  • Neutrophil infiltration was observed in A. baumannii-infected lungs but was limited in P. aeruginosa-infected lungs, with prolonged immune cell accumulation in A. baumannii infections.

Conclusions:

  • Acinetobacter baumannii infection leads to persistent inflammation in the lungs, even with immune cell presence.
  • The pathogen is not fully cleared, indicating a need for further research into infection mechanisms.
  • Development of novel drugs and vaccines is essential to combat A. baumannii infections.

Related Concept Videos